Many common infections respond to cefprozil

July 1995
Modern Medicine;Jul95, Vol. 63 Issue 7, p56
Presents an abstract of the article titled `Cefprozil, a new cephalosporin: Its use in various clinical trials,' by R.B. Gainer II originally published in the March 1995 issue of `South Medical Journal.'


Related Articles

  • Bug beater. Portyansky, Elena // Drug Topics;1/19/98, Vol. 142 Issue 2, p28 

    Presents information on the drug `Omnicef (cefdinir) which is the tenth third-generation cephalosporin in the United States. Indications carried by the extended-spectrum, semisynthetic oral cephalosporin which is manufactured by Warner-Lambert; Details on the availability of Omnicef.

  • Oral, once-daily, broad-spectrum cephalosporin antibiotic.  // Modern Medicine;Mar96, Vol. 64 Issue 3, p32 

    Reports on the approval of Ceftibuten cephalosphorin in the United States for treating mild-to-moderate infections. Conditions allowed for using the drug; Effectivity against strains of Hemophilus influenzae and Moraxella catarrhalis; Dosage; Contraindications.

  • Cefepime is effective against several kinds of infection. Cerrato, Paul L. // RN;Jun96, Vol. 59 Issue 6, p70 

    Focuses on the cephalosporin antibiotic called cefepime for the treatment of urinary tract infections UTIs), skin infections and pneumonia.

  • A new cephalosporin to battle respiratory infections. Cerrato, Paul L. // RN;Jul96, Vol. 59 Issue 7, p70 

    Reports on the US Food and Drug Administration's (FDA) approval of the third-generation oral cephalosporin ceftibuten for patients with chronic bronchitis, acute bacterial otitis media, pharyngitis and tonsillitis. Recommended dosage; Most common adverse reactions.

  • European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997–2009). Versporten, Ann; Coenen, Samuel; Adriaenssens, Niels; Muller, Arno; Minalu, Girma; Faes, Christel; Vankerckhoven, Vanessa; Aerts, Marc; Hens, Niel; Molenberghs, Geert; Goossens, Herman // Journal of Antimicrobial Chemotherapy (JAC);Feb2012, Vol. 67 Issue 2, p518 

    A correction to the article "European Surveillance of Antimicrobial Consumption (ESAC): Outpatient Cephalosporin Use in Europe," published in the 2011 issue, is presented.

  • The cephalosporins: When to use, how to choose. Beam, Thomas R.; Feldman, Richard D. // Patient Care;10/30/1994, Vol. 28 Issue 17, p72 

    Offers advice on how to use and choose cephalosporins for established infections. History; Categories and features; Discussion on activity, toxicity and cost; Possible patient reactions; Recommendation. INSETS: On the horizon: The fourth generation.;When to beware of cephalosporins..

  • Asthma in workers manufacturing cephalosporins. Coutts, I.I.; Dally, M.B.; Taylor, A.J. Newman; Pickering, C.A.C.; Horsfield, N. // British Medical Journal (Clinical Research Edition);10/10/1981, Vol. 283 Issue 6297, p950 

    Examines the incidence of asthma caused by exposure to cephalosporins. Evaluation on the sensitization of exposed persons to cephalosphorins; Determination of inhalant antigens; Complications in asthma-exposed cephalosporins.

  • Any Questions.  // British Medical Journal;6/28/1975, Vol. 2 Issue 5973, p744 

    Publishes a selection of questions and answers on medicine. Evidence that necrotizing jejunitis is an acute bacterial infection; Cause of the bacterial infection; Question on the most effective cephalosporin.

  • Pharmacological Properties of Parenteral Cephalosporins: Rationale for Ambulatory Use. Strehl, E.; Kees, F. // Drugs;Jun2000 Supplement 3, Vol. 59 Issue 6, p9 

    Parenteral cephalosporins are among the most frequently used antibiotics in hospital therapy. They are characterised by an extended spectrum of activity against Gram-positive and Gram-negative bacteria, and some also have good activity against anaerobes. They kill proliferating bacterial cells...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics